FMS-like tyrosine kinase 4
| GO Term | Evidence Code | PMID |
|---|---|---|
| angiogenesis |
|
|
| positive regulation of protein phosphorylation | ||
| positive regulation of endothelial cell proliferation | ||
| positive regulation of endothelial cell proliferation | ||
| vasculature development |
| GO Term | Evidence Code | PMID |
|---|---|---|
| nucleus | ||
| nucleoplasm | ||
| cytoplasm | ||
| cytosol | ||
| plasma membrane |
| GO Term | Evidence Code | PMID |
|---|---|---|
| transmembrane receptor protein tyrosine kinase activity | ||
| GPI-linked ephrin receptor activity | ||
| transmembrane-ephrin receptor activity | ||
| epidermal growth factor receptor activity | ||
| fibroblast growth factor receptor activity |
| Gene Ontology |
|---|
| ATP binding |
| angiogenesis |
| cell migration |
| endothelial cell differentiation |
| growth factor binding |
| metal ion binding |
| nucleotide binding |
| positive regulation of angiogenesis |
| positive regulation of cell migration |
| regulation of MAPK cascade |
| InterPro |
|---|
| Tyrosine-protein kinase, active site |
| Tyrosine-protein kinase, catalytic domain |
| Tyrosine-protein kinase, receptor class III, conserved site |
| VEGFR-2, transmembrane domain |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0050580 | hereditary lymphedema |
| Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
|---|---|---|---|
| 1436 | FB:FBgn0032006 | ||
| 2321 | FB:FBgn0032006 | ||
| 2322 | FB:FBgn0032006 | ||
| 2324 | Xenbase:XB-GENE-483183 | HUMAN82787 | |
| 3791 | FB:FBgn0032006 | ||
| 3815 | FB:FBgn0032006 | ||
| 5156 | WB:WBGene00006894 | ||
| 12978 | WB:WBGene00006894 | ||
| 14254 | FB:FBgn0032006 | ||
| 14255 | FB:FBgn0032006 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025